Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037531 | SCV000061189 | benign | not specified | 2012-02-07 | criteria provided, single submitter | clinical testing | Benign based on high population frequency (17/3755 chromosomes). |
Eurofins Ntd Llc |
RCV000724395 | SCV000229825 | uncertain significance | not provided | 2014-12-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724395 | SCV000534032 | likely benign | not provided | 2020-12-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001087566 | SCV000557930 | benign | Hypertrophic cardiomyopathy 14 | 2023-11-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000724395 | SCV004699084 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | MYH6: BP4, BP7 |
Prevention |
RCV003934912 | SCV004753192 | benign | MYH6-related condition | 2019-06-07 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000037531 | SCV001922277 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000724395 | SCV001927748 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000724395 | SCV001974360 | likely benign | not provided | no assertion criteria provided | clinical testing |